We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
This series brings together all documents relating to drugs licensing.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
We have launched a public consultation on the proposal to reclassify codeine linctus to a prescription-only medicine.
What you need to know and do before you book any travel to the UK.
Find drug safety updates issued by MHRA
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
Explains changes to drug driving law and the guidance available for healthcare professionals and users of prescription medicine.
Information and guidance on a range of medical devices for users and patients.
An overview of the process including submitting or fast-tracking an application, naming your medicine and paying fees.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).